Starting Insulin Dose After DKA Resolution
For a newly diagnosed diabetic patient who has recovered from DKA, start with basal insulin at 0.4-0.5 units/kg/day as the total daily dose (TDD), divided as 50% basal and 50% prandial insulin, distributed across three meals. 1, 2
Initial Dosing Strategy
The starting insulin dose depends on several patient-specific factors:
Standard Dosing (Most Patients)
- TDD: 0.4-0.5 units/kg/day for patients with blood glucose 201-400 mg/dL 2
- Split as:
- 50% basal insulin (given once daily with glargine/detemir or twice daily with NPH/detemir)
- 50% prandial insulin (divided equally before three meals using rapid-acting insulin) 2
Lower Starting Doses (High-Risk Patients)
Reduce to 0.2-0.3 units/kg/day for: 2, 3
- Age ≥70 years
- Glomerular filtration rate <60 mL/min
- Malnutrition or low BMI
- Frail or elderly patients
Higher Doses (Insulin-Resistant Patients)
Consider 0.5 units/kg/day or higher for: 3
- Obesity
- Sedentary lifestyle
- Concurrent steroid use
Practical Example
For a 70 kg patient without high-risk features:
- TDD = 70 kg × 0.4 units/kg = 28 units/day
- Basal insulin: 14 units once daily (glargine) or split twice daily (NPH)
- Prandial insulin: 4-5 units before each meal (rapid-acting analog)
- Add correction doses using a sliding scale 2
Critical Implementation Points
Avoid sliding scale insulin alone - This reactive approach results in 3-fold increased risk of hyperglycemia and delays achieving glycemic targets 2. The newly diagnosed diabetic recovering from DKA requires scheduled basal-bolus insulin, not correction doses alone.
Discontinue oral diabetes medications upon hospital admission or at discharge planning if starting insulin 2. These agents have contraindications in acute settings and delay achieving glycemic control.
Continue basal insulin even when NPO - Patients who cannot eat still require basal insulin to suppress gluconeogenesis and prevent ketone production, especially important in newly diagnosed diabetics who may have type 1 diabetes 2. Hold only the prandial component.
Titration Approach
After initiating therapy 4:
- Adjust insulin every 2-3 days based on fasting and premeal glucose
- Increase by 2 units if 50% of fasting values exceed goal
- Decrease by 10-20% for hypoglycemia <70 mg/dL
- Target fasting glucose <110-140 mg/dL and premeal glucose <110-140 mg/dL
Special Consideration for Type 1 vs Type 2
Since this is a newly diagnosed diabetic presenting in DKA, consider testing for autoimmune diabetes 4. If type 1 diabetes is confirmed or suspected:
- Never discontinue basal insulin, even when fasting
- May require lower initial doses (0.2-0.3 units/kg/day) as type 1 patients typically have less insulin resistance 2
- Failure to provide continuous basal insulin can rapidly lead to recurrent DKA 2
Common Pitfalls to Avoid
Do not use correction insulin alone - This outdated "sliding scale" approach is associated with worse outcomes and should only supplement scheduled insulin 2, 5.
Do not delay insulin initiation - With A1C >10% or glucose ≥300 mg/dL (common post-DKA), insulin is the first-line agent to reduce glucose promptly and safely 1, 4.
Do not forget to reduce home insulin doses if the patient was previously on insulin - Reduce by 20% for patients on basal-heavy regimens (≥0.6 units/kg/day) to prevent hypoglycemia 5.